Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: Data from the enTRD registry.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Preiss M, Popper V, Faber LHC, et al. (2026). "Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: Data from the enTRD registry.". European psychiatry : the journal of the Association of European Psychiatrists. https://doi.org/10.1192/j.eurpsy.2026.12234